Literature DB >> 7507967

Inhibition of activation-induced death in T cell hybridomas by thiol antioxidants: oxidative stress as a mediator of apoptosis.

P A Sandstrom1, M D Mannie, T M Buttke.   

Abstract

N-Acetylcysteine (NAC) is a well established thiol antioxidant which, after uptake, deacylation and conversion to glutathione functions as both a redox buffer and a reactive oxygen intermediate scavenger. We report here that NAC completely blocks activation induced death and associated DNA fragmentation of myelin basic protein (MBP) specific T cell hybridomas. Conversely, NAC had very little effect on the antigen driven proliferation of a MBP specific T cell line similar to that from which the hybridomas were derived. NAC displayed an analogous absolute inhibition of mitogen mediated activation induced death, even if added up to 3 h post activation. Although glutathione was as efficient as NAC at blocking activation induced death, dithiothreitol displayed minimal inhibition while L-cysteine had no effect at all. The observation that certain thiol antioxidants such as NAC and glutathione can completely block the activation induced death of T cell hybridomas implicates redox regulation in this process.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507967     DOI: 10.1002/jlb.55.2.221

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  39 in total

1.  Research communication copper-1,10-phenanthroline induces internucleosomal DNA fragmentation in HepG2 cells, resulting from direct oxidation by the hydroxyl radical.

Authors:  S Y Tsang; S C Tam; I Bremner; M J Burkitt
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

2.  Deciphering the Finger Prints of Brain Cancer Glioblastoma Multiforme from Four Different Patients by Using Near Infrared Raman Spectroscopy.

Authors:  Hirendra Nath Banerjee; Arnold Banerji; Arunendra Nath Banerjee; Eilena Riddick; Jenae Petis; Shavonda Evans; Megha Patel; Carl Parson; Valerie Smith; E Gwebu; Sarah Voisin
Journal:  J Cancer Sci Ther       Date:  2015-02-03

3.  Stretch-induced programmed myocyte cell death.

Authors:  W Cheng; B Li; J Kajstura; P Li; M S Wolin; E H Sonnenblick; T H Hintze; G Olivetti; P Anversa
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

4.  The NF-kappaB inhibitors attenuate hepatic injury in bile duct ligated rats.

Authors:  Savaş Demirbilek; Melih Akin; Kubilay Gürünlüoğlu; Nasuhi E Aydin; Memet H Emre; Erkan Taş; Rauf T Aksoy; Selma Ay
Journal:  Pediatr Surg Int       Date:  2006-07-08       Impact factor: 1.827

5.  N-acetylcysteine inhibits the induction of an antigen-specific antibody response down-regulating CD40 and CD27 co-stimulatory molecules.

Authors:  L Giordani; M G Quaranta; W Malorni; M Boccanera; E Giacomini; M Viora
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

6.  Expression of apoptosis-related oncoproteins and modulation of apoptosis by caffeine in human leukemic cells.

Authors:  T Efferth; U Fabry; P Glatte; R Osieka
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

7.  Nitrone spin traps and a nitroxide antioxidant inhibit a common pathway of thymocyte apoptosis.

Authors:  A F Slater; C S Nobel; E Maellaro; J Bustamante; M Kimland; S Orrenius
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

8.  Control of Bcl-2 expression by reactive oxygen species.

Authors:  David A Hildeman; Thomas Mitchell; Bruce Aronow; Sara Wojciechowski; John Kappler; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

Review 9.  Programmed cell death and radioresistance.

Authors:  R E Meyn; L C Stephens; L Milas
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

10.  Cell density plays a critical role in ex vivo expansion of T cells for adoptive immunotherapy.

Authors:  Qiangzhong Ma; Yawen Wang; Agnes Shuk-Yee Lo; Erica M Gomes; Richard P Junghans
Journal:  J Biomed Biotechnol       Date:  2010-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.